awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37071019-79426E51-9471-4297-B4FA-FCA17AD7B66A
Q37071019-79426E51-9471-4297-B4FA-FCA17AD7B66A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37071019-79426E51-9471-4297-B4FA-FCA17AD7B66A
Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy
P2860
Q37071019-79426E51-9471-4297-B4FA-FCA17AD7B66A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37071019-79426E51-9471-4297-B4FA-FCA17AD7B66A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fa410c6df4a94d440ca23dfb3d833caf8f5e948f
P2860
Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer.